| # | Drug | Count |
|---|---|---|
| 0 | NAPROXEN SODIUM | 11 |
| 1 | NAPROXEN | 7 |
| 2 | ESCITALOPRAM | 6 |
| 3 | ESCITALOPRAM OXALATE | 6 |
| 4 | MELATONIN | 6 |
| 5 | ESCITSLOPRAM | 5 |
| 6 | DOLUTEGRAVIR SODIUM | 4 |
| 7 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 9 | NAPROXEN SODIUM 220MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 4 | 0.0128 |
| 1 | DOLUTEGRAVIR SODIUM | 4 | 0.0004 |
| 2 | NAPROXEN SODIUM 220MG | 4 | 0.0003 |
| 3 | MELATONIN | 6 | 0.0001 |
| 4 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 4 | 0.0001 |
| 5 | TIMOLOL | 1 | 0.0001 |
| 6 | NAPROXEN SODIUM | 11 | 0.0001 |
| 7 | ESCITALOPRAM | 6 | 0.0000 |
| 8 | CARBOPLATIN | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 2 | 0.0000 |